Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1997 Jun;44(3):165–172. doi: 10.1007/s002620050369

Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages

S T Dougherty 1, Connie J Eaves 2, William H McBride 4, Graeme J Dougherty 2
PMCID: PMC11037795  PMID: 9191876

Abstract

 In order to better define the role played by tumor-cell-derived macrophage-colony-stimulating factor (M-CSF) in regulating the recruitment and phenotype of tumor-associated macrophages, Polyoma large T-transformed fibroblastoid cell lines, derived from M-CSF-deficient osteopetrotic op/op mice and their phenotypically normal op/+ littermate controls, were inoculated into SCID (severe combined immunodeficiency) recipients and both the proportion and phenotype of the macrophages present within the tumors generated were determined. The results obtained indicate that, although tumors derived from M-CSF-deficient and M-CSF-producing tumor cell inoculate contain a similar proportion of macrophages, the macrophages isolated from tumors lacking M-CSF appear morphologically less mature and express lower levels of interleukin 1β, tumor necrosis factor α and FcRγII mRNA. Taken together, these data suggest that, although M-CSF does not appear to play a critical role in determining the macrophage content of these tumors, it does play a role in modulating the phenotype, and potentially the functional activity of the macrophages present within the tumor microenvironment.

Keywords: Key words Tumor-associated macrophages, M-CSF, op/op mice

Footnotes

Received: 30 August 1996 / Accepted: 7 February 1997


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES